Characteristics | n = 38 |
---|---|
Age (years) | 53 (34-77) |
Male | 33 (86.8) |
Etiology | |
 HBV | 29 (76.3) |
 HCV | 1 (4.8) |
 NBNC | 8 (18.9) |
Liver cirrhosis | 30 (78.9) |
Child-Pugh class (A/B) | |
 Class A | 32 (84.2) |
 Class B | 6 (15.8) |
ECOG performance status | Â |
 Grade 0 | 5 (13.2) |
 Grade 1 | 33 (86.8) |
Vascular invasion | |
 Main portal trunk invasion | 16 (42.1) |
 Left of right lobar portal vein invasion | 15 (39.5) |
 Segmental portal vein invasion | 5 (13.1) |
 Hepatic vein invasion | 2 (5.3) |
BCLC stage | |
 Advanced (C) | 38 (100) |
AJCC stage | |
 IIIB | 20 (52.6) |
 IIIC | 1 (2.6) |
 IVA | 15 (39.5) |
 IVB | 2 (5.3) |
Tumor size (cm) | 11.6 (3.5-21.1) |
AFP (ng/mL) | 1573.0 (2.0-54,000) |
DCP (mAU/mL) | 4378.0 (18.0-75,000) |
Radiation dose (cGy) | 4500 (3060-6250) |
Round of HAIC | 3.5 (0-18) |
TACE | 19 (50.0) |
 For local residual tumor | 6 (31.6) |
 For newly recurring tumor | 13 (68.4) |